Cargando…

Understanding the natural progression in %FEV(1) decline in patients with cystic fibrosis: a longitudinal study

BACKGROUND: Forced expiratory volume in 1 s as a percentage of predicted (%FEV(1)) is a key outcome in cystic fibrosis (CF) and other lung diseases. As people with CF survive for longer periods, new methods are required to understand the way %FEV(1) changes over time. An up to date approach for long...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor-Robinson, David, Whitehead, Margaret, Diderichsen, Finn, Olesen, Hanne Vebert, Pressler, Tania, Smyth, Rosalind L, Diggle, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446776/ https://www.ncbi.nlm.nih.gov/pubmed/22555277 http://dx.doi.org/10.1136/thoraxjnl-2011-200953

Ejemplares similares

Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population
por: Taylor-Robinson, David C., et al.
Publicado: (2014)

Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis()
por: Qvist, Tavs, et al.
Publicado: (2016)

A Longitudinal Study of the Impact of Social Deprivation and Disease Severity on Employment Status in the UK Cystic Fibrosis Population
por: Taylor-Robinson, David C., et al.
Publicado: (2013)

The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study
por: Taylor-Robinson, David C, et al.
Publicado: (2013)

Being affiliated to a cystic fibrosis centre is important for parents' everyday life
por: Nielsen, Pia Bonde, et al.
Publicado: (2022)

Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis
por: Bouzek, Drake C., et al.
Publicado: (2022)

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis
por: Boëlle, Pierre-Yves, et al.
Publicado: (2012)

The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry
por: Viviani, Laura, et al.
Publicado: (2014)

Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis
por: Pedersen, Maya Graham, et al.
Publicado: (2015)

Routine spirometry in cystic fibrosis patients: impact on pulmonary exacerbation diagnosis and FEV(1) decline
por: de Aquino, Carolina Silva Barboza, et al.
Publicado: (2022)

Exercise and quality of life in patients with cystic fibrosis: A 12-week intervention study
por: Schmidt, Anne Mette, et al.
Publicado: (2011)

Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations
por: Qvist, Tavs, et al.
Publicado: (2019)

Comparing cystic fibrosis outcomes across the pond
por: Taylor-Robinson, David C, et al.
Publicado: (2015)

Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis
por: Qvist, Tavs, et al.
Publicado: (2014)

Reliability of FEV(1)/FEV(6) to Diagnose Airflow Obstruction Compared with FEV(1)/FVC: The PLATINO Longitudinal Study
por: Perez-Padilla, Rogelio, et al.
Publicado: (2013)

Impact of cystic fibrosis on birthweight: a population based study of children in Denmark and Wales
por: Schlüter, Daniela K, et al.
Publicado: (2019)

Median regression spline modeling of longitudinal FEV(1) measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients
por: Conrad, Douglas J., et al.
Publicado: (2017)

Rate of Decline of FEV(1) as a Biomarker of Survival?
por: Papi, Alberto, et al.
Publicado: (2021)

Rhinovirus‐associated pulmonary exacerbations show a lack of FEV (1) improvement in children with cystic fibrosis
por: Cousin, Mathias, et al.
Publicado: (2016)

Using different methods to process forced expiratory volume in one second (FEV (1)) data can impact on the interpretation of FEV (1) as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart review
por: Hoo, Zhe Hui, et al.
Publicado: (2018)

Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

Obstructive sleep apnoea accelerates FEV(1) decline in asthmatic patients
por: Wang, Tsai-Yu, et al.
Publicado: (2017)

Nationwide lung function monitoring from infancy in newborn-screened children with cystic fibrosis
por: Sandvik, Rikke M., et al.
Publicado: (2023)

A multicentre, randomised intervention study of the Paediatric Early Warning Score: study protocol for a randomised controlled trial
por: Jensen, Claus Sixtus, et al.
Publicado: (2017)

Serum Th‐2 cytokines and FEV(1) decline in WTC‐exposed firefighters: A 19‐year longitudinal study
por: Weiden, Michael D., et al.
Publicado: (2021)

Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis
por: Pressler, Tacjana
Publicado: (2008)

Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns
por: Aghili, Rokhsareh, et al.
Publicado: (2013)

Systematic review of the evidence relating FEV(1 )decline to giving up smoking
por: Lee, Peter N, et al.
Publicado: (2010)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

EPS4.4 Correlation between long-term changes in LCI, FEV(1) and CFCT score in children with cystic fibrosis
por: Vermeulen, F., et al.
Publicado: (2017)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

Consensus on patient cases for hospitalised children with a high paediatric track and trigger tool score that raises no mounting concern: a Delphi process study
por: Jensen, Claus Sixtus, et al.
Publicado: (2022)

Decline in FEV(1) and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
por: Hiller, Adriana-Maria, et al.
Publicado: (2019)

Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART
por: Samperiz, Gloria, et al.
Publicado: (2019)

Antibiotic duration and changes in FEV(1) are not associated with time until next exacerbation in adult cystic fibrosis: a single center study
por: Espel, Julia C., et al.
Publicado: (2017)

An interaction between Nrf2 polymorphisms and smoking status affects annual decline in FEV(1): a longitudinal retrospective cohort study
por: Masuko, Hironori, et al.
Publicado: (2011)

Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia
por: Qvist, Tavs, et al.
Publicado: (2015)

Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity
por: Mehrparvar, Amir Houshang, et al.
Publicado: (2014)

Time Free From Hospitalization in Children and Adolescents With Cystic Fibrosis: Findings From FEV(1), Lung Clearance Index and Peak Work Rate
por: Gambazza, Simone, et al.
Publicado: (2022)

Genome organization and molecular characterization of the three Formica exsecta viruses—FeV1, FeV2 and FeV4
por: Dhaygude, Kishor, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_abcaq4q3pcqrehl06bhb43776n